Chemomab Therapeutics (CMMB) Institutional Ownership $1.12 -0.04 (-3.45%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.13 +0.01 (+0.80%) As of 04/17/2025 04:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Chemomab Therapeutics (NASDAQ:CMMB)CurrentInstitutional OwnershipPercentage46.05%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.95MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$118.72K Get CMMB Insider Trade Alerts Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CMMB Institutional Buying and Selling by Quarter Chemomab Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025XTX Topco Ltd24,929$45K0.0%+63.8%0.174% 2/11/2025Virtu Financial LLC14,445$26K0.0%N/A0.101% 2/5/2025Yelin Lapidot Holdings Management Ltd.744,127$1.35M0.2%-8.1%5.182% 11/15/2024Sphera Funds Management LTD.1,214,575$1.91M0.3%N/A8.458% 2/1/2023Kestra Private Wealth Services LLC31,241$100K0.0%N/A0.271% 2/14/2022GSA Capital Partners LLP11,277$78K0.0%N/A0.099% 1/28/2022ARK Investment Management LLC267,292$1.84M0.0%+48.1%2.344% 11/17/2021Yahav Achim Ve Achayot Provident Funds Management Co Ltd.3,097$34K0.0%N/A0.027% 11/5/2021Advisor Group Holdings Inc.54,821$608K0.0%N/A0.481% 11/3/2021Meitav Dash Investments Ltd.37,567$416K0.0%-7.6%0.330% 9/17/2021Virtu Financial LLC13,180$251K0.0%N/A0.116% 8/25/2021Marshall Wace LLP63,554$1.21M0.0%N/A0.558% 8/25/2021Marshall Wace North America L.P.44,035$837K0.0%N/A0.386% 8/18/2021Ikarian Capital LLC290,534$5.53M0.4%N/A2.640% 8/18/2021Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.370% 8/17/2021Boothbay Fund Management LLC54,729$1.04M0.0%-11.4%0.512% 8/16/2021Marshall Wace LLP63,554$1.21M0.0%N/A0.594% 8/5/2021Meitav Dash Investments Ltd.40,664$773K0.0%+389.3%0.380% 5/18/2021Orbimed Advisors LLC2,578,174$74.02M0.7%N/A110.320% 5/13/2021Renaissance Technologies LLC7,023$202K0.0%N/A0.301% 5/6/2021Meitav Dash Investments Ltd.8,311$239K0.0%N/A0.356% (Data available from 1/1/2016 forward) CMMB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CMMB shares? During the previous two years, the following institutional investors and hedge funds held shares of Chemomab Therapeutics shares: Sphera Funds Management LTD. ($1.91M), Yelin Lapidot Holdings Management Ltd. ($1.35M), and XTX Topco Ltd ($45K), Virtu Financial LLC ($26K).Learn more on CMMB's institutional investors. What percentage of Chemomab Therapeutics stock is owned by institutional investors? 46.05% of Chemomab Therapeutics stock is owned by institutional investors. Learn more on CMMB's institutional investor holdings. Which institutional investors have been buying Chemomab Therapeutics stock? The following institutional investors have purchased Chemomab Therapeutics stock in the last 24 months: Sphera Funds Management LTD. ($1.21M), Virtu Financial LLC ($14.45K), and XTX Topco Ltd ($9.71K). How much institutional buying is happening at Chemomab Therapeutics? Institutional investors have bought a total of 1,238,726 shares in the last 24 months. This purchase volume represents approximately $1.95M in transactions. Which Chemomab Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Chemomab Therapeutics stock in the last 24 months: Yelin Lapidot Holdings Management Ltd. ($65.59K). How much institutional selling is happening at Chemomab Therapeutics? Institutional investors have sold a total of 65,590 shares in the last 24 months. This volume of shares sold represents approximately $118.72K in transactions. Related Companies CABA Institutional Ownership INZY Institutional Ownership ASRT Institutional Ownership UNCY Institutional Ownership CNTX Institutional Ownership QNCX Institutional Ownership JSPR Institutional Ownership MGX Institutional Ownership MDCX Institutional Ownership CTOR Institutional Ownership This page (NASDAQ:CMMB) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMMB Stock Free CMMB Stock Alerts